Transarterial chemoembolization (TACE) has been used extensively to treat tumours confined to the liver in patients unsuitable for surgical resection. This study attempts to identify patients with liver cancer most likely to benefit from this type of treatment.
|Number of pages||5|
|Journal||EJSO - European Journal of Surgical Oncology|
|Publication status||Published - 2004|